•
PC
PCVX
Vaxcyte, Inc. Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
6.57B
Volume
1.08M
52W High
$93.77
52W Low
$27.66
Open
$0.00
Prev Close
$47.52
Day Range
0.00 - 0.00
About Vaxcyte, Inc. Common Stock
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Latest News
Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown
Benzinga•Sep 30
Pneumococcal Infections Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight
GlobeNewswire Inc.•Aug 21
Vaxcyte (PCVX) Q2 Loss Widens 11%
The Motley Fool•Aug 7
Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine
Benzinga•Mar 31
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm
GlobeNewswire Inc.•Jan 30
Trump and Interest Rates: The 2 Key Reasons This Vanguard ETF Could Thrive in 2025
The Motley Fool•Jan 1
Vaxcyte Announces Pricing of $1.3 Billion Public Offering
GlobeNewswire Inc.•Sep 5
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.•Sep 3